<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>1327168</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Martínez Zapico, R</dc:author>
<dc:author>Sobejano, L</dc:author>
<dc:author>Llamazares, I</dc:author>
<dc:author>Ladrón de Guevara, C</dc:author>
<dc:description xml:lang="en">BACKGROUND Evaluation of two commercial immunoenzymatic techniques (ELISA) for detection of anti-EBNA-1 IgG and IgM for diagnosis of Epstein-Barr virus mononucleosis. METHODS Study of anti-EBNA-1 IgG and IgM in infectious mononucleosis and they have been compared with the detection of IgM antibodies to VCA by indirect immunofluorescence as the reference method. RESULTS The sensitivity of the assay was 87.5%, the specificity was 89.4%, the positive predictive value was 91.4% and the negative predictive value was 85%. CONCLUSIONS This technique can be useful in laboratories without the necessary equipment and experienced personnel for indirect immunofluorescence. It also can be used as a complementary determination to the anti-VCA IgM in the long lasting infectious mononucleosis, when this marker is negative.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>1992 May </dc:date>
<dc:title xml:lang="es">Estudio y valoración de anticuerpos IgG-IgM frente al antígeno nuclear del virus de Epstein-Barr (EBNA-1) mediante ELISA.</dc:title>
<dc:title xml:lang="en">[Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].</dc:title>
<dc:publisher>Enfermedades infecciosas y microbiologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
